Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
Revenue Growth TrendStable
Percentile Rank64
3Y CAGR+41.8%
5Y CAGR-12.1%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+41.8%/yr
Annual compound
5Y CAGR
-12.1%/yr
Recent acceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 65.19% |
| 2024 | 22.97% |
| 2023 | 76.23% |
| 2022 | 22.88% |
| 2021 | 71.31% |
| 2020 | 124.28% |
| 2019 | 193.36% |
| 2018 | -16.69% |
| 2017 | 90.66% |
| 2016 | 14.75% |